PHOTO IMAGE
Year : 2018 | Volume
: 56 | Issue : 4 | Page : 276-
Anteriorly migrated dexamethasone implant
Premanand Chandran1, Ganesh V Raman1, Veerappan R Saravanan2, 1 Glaucoma Services, Aravind Eye Hospital, Coimbatore, Tamil Nadu, India 2 Retina Services, Aravind Eye Hospital, Coimbatore, Tamil Nadu, India
Correspondence Address:
Dr. Premanand Chandran Aravind Eye Hospital, Avinashi Road, Coimbatore - 641 014, Tamil Nadu India
How to cite this article:
Chandran P, Raman GV, Saravanan VR. Anteriorly migrated dexamethasone implant.TNOA J Ophthalmic Sci Res 2018;56:276-276
|
How to cite this URL:
Chandran P, Raman GV, Saravanan VR. Anteriorly migrated dexamethasone implant. TNOA J Ophthalmic Sci Res [serial online] 2018 [cited 2023 Feb 3 ];56:276-276
Available from: https://www.tnoajosr.com/text.asp?2018/56/4/276/252487 |
Full Text
A 62-year-old female with pseudoexfoliation glaucoma underwent trabeculectomy followed by cataract surgery (lens removal with implantation of the scleral-fixated intraocular lens [SFIOL]) in the right eye. Postoperatively, her visual acuity was 6/60 with cystoid macular edema (central macular thickness was 948 μm), which was recalcitrant to topical steroids [Figure 1]a. She underwent intravitreal injection of dexamethasone implant (Ozurdex). Two weeks postinjection, the implant had migrated anteriorly between the iris and SFIOL [Figure 1]b, but the patient was asymptomatic. Two months later, her visual acuity improved to 6/12 with complete resolution of cystoid macular edema [Figure 1]c.{Figure 1}
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
|